Robotic-assisted middle pancreatectomy versus open middle pancreatectomy in patients with benign or borderline tumor of pancreatic neck and body: A randomized controlled trial

Not Applicable

Recruiting

• Conditions: Confirmed or suspected borderline or benign tumors of the pancreatic neck and body; Surgery - Surgical techniques; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12614000882628
• Lead Sponsor: Ruijin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

(1) a tumor in the middle pancreas that was at least 5 cm from the pancreatic tail and might involve the pancreatic duct; (2) a tumor size less than 10 cm; (3) a benign or borderline tumor, such as an endocrine tumor, a serous or mucinous adenoma, a noninvasive intraductal papillary tumor (IPMTs) or a solid-pseudopapillary tumor (SPTs); and (4) pancreatic cystic tumors (lymphoepithelial cysts, dermoid cysts and hydatid cysts) that would be difficult to excise locally.

Exclusion Criteria

(1) had severe underlying cardiopulmonary disease with poor heart and lung function, (2) could not tolerate anesthesia, (3) had a previous history of abdominal surgery that had resulted in severe abdominal adhesions, (4) scheduled for surgical treatment other than middle pancreatectomy such as distal pancreatectomy, (5) refusal to participate in or withdrawing from this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ength of hospital stay are calculated by subtracting day of admission from day of discharge.[From admission to discharge]